Compare CERT & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CERT | QDEL |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | 2022 |
| Metric | CERT | QDEL |
|---|---|---|
| Price | $7.75 | $17.49 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | $11.67 | ★ $28.25 |
| AVG Volume (30 Days) | ★ 3.7M | 1.1M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | $418,838,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $4.18 | $3.51 |
| Revenue Next Year | $5.39 | $3.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $4.45 | $9.92 |
| 52 Week High | $13.88 | $35.58 |
| Indicator | CERT | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | N/A |
| Support Level | $6.57 | N/A |
| Resistance Level | $7.44 | N/A |
| Average True Range (ATR) | 0.37 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 22.86 | 0.00 |
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.